Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
- PMID: 15564462
- PMCID: PMC533948
- DOI: 10.1128/JVI.78.24.13512-13521.2004
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
Abstract
In 2001, highly evolved type 1 circulating vaccine-derived poliovirus (cVDPV) was isolated from three acute flaccid paralysis patients and one contact from three separate communities in the Philippines. Complete genomic sequencing of these four cVDPV isolates revealed that the capsid region was derived from the Sabin 1 vaccine strain but most of the noncapsid region was derived from an unidentified enterovirus unrelated to the oral poliovirus vaccine (OPV) strains. The sequences of the cVDPV isolates were closely related to each other, and the isolates had a common recombination site. Most of the genetic and biological properties of the cVDPV isolates were indistinguishable from those of wild polioviruses. However, the most recently identified cVDPV isolate from a healthy contact retained the temperature sensitivity and partial attenuation phenotypes. The sequence relationships among the isolates and Sabin 1 suggested that cVDPV originated from an OPV dose given in 1998 to 1999 and that cVDPV circulated along a narrow chain of transmission. Type 1 cVDPV was last detected in the Philippines in September 2001, and population immunity to polio was raised by extensive OPV campaigns in late 2001 and early 2002.
Figures





Similar articles
-
Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.J Virol. 2015 Oct 14;90(1):317-31. doi: 10.1128/JVI.01532-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26468545 Free PMC article.
-
Acute flaccid paralysis associated with circulating vaccine-derived poliovirus--Philippines, 2001.MMWR Morb Mortal Wkly Rep. 2001 Oct 12;50(40):874-5. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11666115
-
Circulating vaccine-derived polioviruses: current state of knowledge.Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106296 Free PMC article. Review.
-
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.J Virol. 2003 Aug;77(15):8366-77. doi: 10.1128/jvi.77.15.8366-8377.2003. J Virol. 2003. PMID: 12857906 Free PMC article.
-
[Eradication of poliomyelitis and emergence of pathogenic vaccine-derived polioviruses: from Madagascar to Cameroon].Med Sci (Paris). 2013 Nov;29(11):1034-41. doi: 10.1051/medsci/20132911021. Epub 2013 Nov 20. Med Sci (Paris). 2013. PMID: 24280508 Review. French.
Cited by
-
Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.J Clin Microbiol. 2010 Sep;48(9):3274-80. doi: 10.1128/JCM.00712-10. Epub 2010 Jul 14. J Clin Microbiol. 2010. PMID: 20631095 Free PMC article.
-
Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region.PLoS One. 2010 Dec 21;5(12):e15300. doi: 10.1371/journal.pone.0015300. PLoS One. 2010. PMID: 21203565 Free PMC article.
-
Formulation technologies for oral vaccines.Clin Exp Immunol. 2019 Nov;198(2):153-169. doi: 10.1111/cei.13352. Epub 2019 Aug 8. Clin Exp Immunol. 2019. PMID: 31318446 Free PMC article. Review.
-
Exchanges of genomic domains between poliovirus and other cocirculating species C enteroviruses reveal a high degree of plasticity.Sci Rep. 2016 Dec 13;6:38831. doi: 10.1038/srep38831. Sci Rep. 2016. PMID: 27958320 Free PMC article.
-
Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.BMC Infect Dis. 2017 Dec 2;17(1):742. doi: 10.1186/s12879-017-2849-z. BMC Infect Dis. 2017. PMID: 29197328 Free PMC article.
References
-
- Alexander, J. P., Jr., H. E. Gary, Jr., and M. A. Pallansch. 1997. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J. Infect. Dis. 175(Suppl. 1):S176-S182. - PubMed
-
- Bellmunt, A., G. May, R. Zell, P. Pring-Akerblom, W. Verhagen, and A. Heim. 1999. Evolution of poliovirus type I during 5.5 years of prolonged internal replication in an immunodeficient patient. Virology 265:178-184. - PubMed
-
- Benyesh-Melnick, M., J. L. Melnick, W. E. Rawls, I. Wimberley, J. Barrera-Oro, E. Ben-Porath, and V. Rennick. 1967. Studies on the immunogenicity, communicability, and genetic stability of oral poliovaccine administered during the winter. Am. J. Epidemiol. 86:112-136. - PubMed
-
- Blomqvist, S., A. L. Bruu, M. Stenvik, and T. Hovi. 2003. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J. Gen. Virol. 84:573-580. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical